[go: up one dir, main page]

WO2010018474A3 - Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques - Google Patents

Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques Download PDF

Info

Publication number
WO2010018474A3
WO2010018474A3 PCT/IB2009/053131 IB2009053131W WO2010018474A3 WO 2010018474 A3 WO2010018474 A3 WO 2010018474A3 IB 2009053131 W IB2009053131 W IB 2009053131W WO 2010018474 A3 WO2010018474 A3 WO 2010018474A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
biological uses
novel
glucopyranose derivatives
novel glucopyranose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2009/053131
Other languages
English (en)
Other versions
WO2010018474A2 (fr
Inventor
Robert Vachy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to JP2011522570A priority Critical patent/JP2011530579A/ja
Priority to US12/737,748 priority patent/US20110136748A1/en
Priority to CN2009801354392A priority patent/CN102149723A/zh
Priority to EP09786642A priority patent/EP2321329A2/fr
Priority to CA2734191A priority patent/CA2734191A1/fr
Publication of WO2010018474A2 publication Critical patent/WO2010018474A2/fr
Publication of WO2010018474A3 publication Critical patent/WO2010018474A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/08—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals directly attached to carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention a pour objet un nouvel ester, le 3,5-di-tertiobutyl-4-hyclroxybenzoate de 3,4,5-trihydroxy-6-méthoxy tétrahydropyran-2-yl méthyl défini par la formule (I) suivante : L'invention concerne également le procédé de préparation du composé de formule (I) et l'utilisation dudit composé (I) pour la préparation d'un médicament destiné au traitement et/ou à la prévention des infections par des virus à enveloppe.
PCT/IB2009/053131 2008-08-12 2009-07-20 Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques Ceased WO2010018474A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2011522570A JP2011530579A (ja) 2008-08-12 2009-07-20 新規グルコース誘導体、その製剤および生物学的用途
US12/737,748 US20110136748A1 (en) 2008-08-12 2009-07-20 Novel glucopyranose derivatives, preparation thereof, and biological uses thereof
CN2009801354392A CN102149723A (zh) 2008-08-12 2009-07-20 新型吡喃葡萄糖衍生物、其制备和其生物学应用
EP09786642A EP2321329A2 (fr) 2008-08-12 2009-07-20 Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques
CA2734191A CA2734191A1 (fr) 2008-08-12 2009-07-20 Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0804572A FR2934998B1 (fr) 2008-08-12 2008-08-12 Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques
FR08/04572 2008-08-12

Publications (2)

Publication Number Publication Date
WO2010018474A2 WO2010018474A2 (fr) 2010-02-18
WO2010018474A3 true WO2010018474A3 (fr) 2010-04-29

Family

ID=40524524

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/053131 Ceased WO2010018474A2 (fr) 2008-08-12 2009-07-20 Nouveaux derives de glucopyranose, leur preparation et leurs applications biologiques

Country Status (7)

Country Link
US (1) US20110136748A1 (fr)
EP (1) EP2321329A2 (fr)
JP (1) JP2011530579A (fr)
CN (1) CN102149723A (fr)
CA (1) CA2734191A1 (fr)
FR (1) FR2934998B1 (fr)
WO (1) WO2010018474A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013133419A1 (fr) * 2012-03-08 2013-09-12 国立大学法人九州大学 Nouvel agent gélifiant dérivé de sucre
DE102019210040A1 (de) * 2019-07-08 2021-01-14 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verwendung von phenolisch substituierten Zuckerderivaten als Stabilisatoren, Kunststoffzusammensetzung, Verfahren zur Stabilisierung von Kunststoffen sowie phenolisch substituierte Zuckerderivate
CN111658631A (zh) * 2020-06-11 2020-09-15 广东盛普生命科技有限公司 没食子酸及其衍生物和结构类似物在制备抗冠状病毒药物方面的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870157A (en) * 1985-07-09 1989-09-26 Olin Corporation Selected 4-acyl-2,6-dialkylphenol adducts of saccharides and their use as stabilizers of organic materials against oxidative degradation
FR2887249A1 (fr) * 2005-06-21 2006-12-22 Rdw Pharma Soc Par Actions Sim Compose d-glucopyranose 1-[3,5-bis(1,1-dimenthylethyl)-4- hydroxybenzoate] et ses derives, leur preparation et leurs utilisations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833155A (en) * 1986-11-25 1989-05-23 Syntex (U.S.A.) Inc. 3-(ω-(3,5,-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles, and anti-inflammatory uses thereof
US5312837A (en) * 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870157A (en) * 1985-07-09 1989-09-26 Olin Corporation Selected 4-acyl-2,6-dialkylphenol adducts of saccharides and their use as stabilizers of organic materials against oxidative degradation
FR2887249A1 (fr) * 2005-06-21 2006-12-22 Rdw Pharma Soc Par Actions Sim Compose d-glucopyranose 1-[3,5-bis(1,1-dimenthylethyl)-4- hydroxybenzoate] et ses derives, leur preparation et leurs utilisations

Also Published As

Publication number Publication date
FR2934998B1 (fr) 2010-09-03
FR2934998A1 (fr) 2010-02-19
WO2010018474A2 (fr) 2010-02-18
JP2011530579A (ja) 2011-12-22
EP2321329A2 (fr) 2011-05-18
CA2734191A1 (fr) 2010-02-18
CN102149723A (zh) 2011-08-10
US20110136748A1 (en) 2011-06-09

Similar Documents

Publication Publication Date Title
MX2011012122A (es) Derivados de tiofeno.
WO2008100867A3 (fr) Nouveaux inhibiteurs de réplication du virus de l'hépatite c
WO2012083122A8 (fr) Inhibiteurs de la réplication du virus de la grippe
WO2009080203A3 (fr) Dérivés d'aminobenzamide utiles en tant qu'agents pour lutter contre les parasites chez des animaux
WO2008115281A3 (fr) Composés de traitement d'infections virales
WO2007135527A3 (fr) Composés de benzimidazolyle
WO2013091775A3 (fr) Utilisation de dérivés du cyclohéxanol comme principes actifs antimicrobiens
WO2009111700A3 (fr) Oxadiazoanthracènes pour le traitement du diabète
BRPI1013394A2 (pt) "composto, composição farmacêutica, uso do composto, e, método para tratar um paciente infectado com virus da hepatite c."
WO2009095226A3 (fr) Acides nucléiques de formule (i) (n<sb>u</sb>g<sb>l</sb>x<sb>m</sb>g<sb>n</sb>n<sb>v</sb>)<sb>a</sb> et leurs dérivés sous forme d'immunostimulant/adjuvant
WO2010093849A3 (fr) Dérivés de la phénylalanine-amide utiles pour le traitement de maladies et états liés à l'insuline
WO2007101864A3 (fr) Nouveaux composés, leur préparation et utilisation
WO2008001195A3 (fr) Nouveaux procédés de synthèse d'inhibiteurs de dpp iv
WO2008017381A8 (fr) Imidazolidin-2,4-dione arylaminoaryl-alkyl-substituée, son procédé de fabrication, médicament contenant ce composé et son utilisation
WO2008062376A3 (fr) Procédé de fabrication de dérivés de 2-imino-thiazolidino-4-one
WO2008147557A3 (fr) Thiazoles à substitution hétéroaryle
FR2934596B1 (fr) Nouveaux derives de l'oxime de cholest-4-en-3-one, compositions pharmaceutiques les renfermant, et procede de preparation
WO2009100936A3 (fr) Nouveaux dérivés aromatiques de glycoside fluoré, médicaments contenant ces composés et leur utilisation
WO2010067078A8 (fr) Sels de xanthylium disubstitués en 3 et 6
WO2008006795A3 (fr) Composés d'indole
WO2009074247A8 (fr) Nouveaux dérivés d'amide d'acide 2-arylthiazole-4-carboxylique, leur préparation et leur utilisation en tant que médicament
WO2008098978A3 (fr) Composés de benzofurane
WO2009105969A8 (fr) Analogues d'épothilone, leurs compositions pharmaceutiques, leur utilisation et leurs préparations
WO2007041632A3 (fr) Procedes et compositions pharmaceutiques pour traiter et prevenir une infection par le virus de l'hepatite c
WO2008116663A3 (fr) Dérivés de tétrahydro-naphtalène-amine substitués par un hétérocyclyle, leur préparation et utilisation en tant que médicaments

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980135439.2

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09786642

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 2734191

Country of ref document: CA

Ref document number: 12737748

Country of ref document: US

ENP Entry into the national phase

Ref document number: 2011522570

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009786642

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1562/DELNP/2011

Country of ref document: IN